Adhera Therapeutics (ATRX) News Today

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

$0.0060

0.00 (0.00%)

(As of 04/19/2024 ET)

Stock Analysis Chart Earnings Financials SEC Filings Short Interest

Source

Source	Headline
	Adhera Therapeutics Inc (ATRX) investing.com - January 30 at 8:29 AM
	ATRX Adhera Therapeutics, Inc. seekingalpha.com - August 24 at 9:59 PM
	Intensity Therapeutics upsizes proposed IPO to $15M from $8M seekingalpha.com - May 22 at 12:52 AM
	Adhera Therapeutics, Inc. (ATRX) finance.yahoo.com - February 27 at 12:45 AM
	Adhera Therapeutics to Collaborate with Alberta Diabetes Institute, University of Alberta to Initiate Clinical Trial of MLR-1023 in Type 1 Diabetes finance.yahoo.com - January 25 at 1:01 PM
	CGTX Cognition Therapeutics, Inc. seekingalpha.com - January 18 at 6:43 PM
	Adhera Therapeutics files for Nasdaq uplisting, $35M offering seekingalpha.com - December 5 at 8:37 PM
	Adhera Therapeutics Stock (OTC:ATRXD), Analyst Ratings, Price Targets, Predictions benzinga.com - October 9 at 10:29 PM
	Adhera Therapeutics Announces CEO, Senior... benzinga.com - September 21 at 2:56 AM
	Adhera Therapeutics Announces CEO, Senior Management Changes, Plans for NASDAQ Uplist finance.yahoo.com - September 19 at 9:56 AM
	Adhera Therapeutics gains on announcing CEO, senior management changes, plans for NASDAQ uplist seekingalpha.com - September 19 at 9:56 AM
	Adhera Therapeutics Signs Letter of Intent to Acquire CD71-Targeted Cancer Therapy Paclitaxel Gallium Transferrin finance.yahoo.com - July 19 at 1:49 PM
	Adhera Therapeutics appoints new Chairman of the Board, focuses on uplist to Nasdaq seekingalpha.com - May 19 at 6:20 PM
	Adhera Therapeutics Appoints Trond K. Waerness as Chairman of the Board, Company Focuses on Uplist to NASDAQ finance.yahoo.com - May 19 at 6:20 PM
	Adhera Therapeutics Announces Uplisting to OTCQB Venture Marketplace finance.yahoo.com - January 20 at 1:20 PM
	Adhera Therapeutics Receives Notice of Allowance for New Canadian Patent Covering MLR-1019 for Dyskinesia and Related Disorders finance.yahoo.com - November 22 at 11:41 AM
	Adhera Therapeutics Announces Appointment of Dr. Zahed Subhan to Board of Directors finance.yahoo.com - November 8 at 9:27 AM
	Adhera Therapeutics Expands Relationship with Melior Pharmaceuticals I, Adds NASH and Pulmonary ... apnews.com - October 20 at 1:13 PM
	Adhera Therapeutics Expands Relationship with Melior Pharmaceuticals I, Adds NASH and Pulmonary Inflammation to Portfolio of Target Indications finance.yahoo.com - October 20 at 1:13 PM
	Manufacturing Commences on Adhera’s MLR-1019 for Phase 2a Clinical Trial Treating Parkinson’s ... apnews.com - October 16 at 1:09 PM
	Manufacturing Commences on Adhera’s MLR-1019 for Phase 2a Clinical Trial Treating Parkinson’s Disease finance.yahoo.com - October 15 at 3:18 PM
	Adhera Receives European Patent Covering MLR-1019 and Derivatives for Treating Dyskinesias finance.yahoo.com - October 4 at 1:41 PM
	5 Penny Stocks with Upcoming Growth Catalysts insidermonkey.com - September 15 at 5:52 PM
	Adhera Therapeutics Provides Insight on Corporate Strategy, Development of Parkinson’s Disease ... apnews.com - September 13 at 4:29 PM
	Adhera Therapeutics Provides Insight on Corporate Strategy, Development of Parkinson’s Disease and Type 1 Diabetes Drugs finance.yahoo.com - September 13 at 4:29 PM
	Adhera Therapeutics Appoints Dr. Andrew Reaume to Board of Directors finance.yahoo.com - September 9 at 11:34 AM
	Adhera Therapeutics Signs Exclusive License Agreement with Melior Pharmaceuticals I for New ... apnews.com - August 24 at 5:04 PM
	Adhera Therapeutics Signs Exclusive License Agreement with Melior Pharmaceuticals I for New Type 1 Diabetes Drug Candidate finance.yahoo.com - August 24 at 5:04 PM
	Melior Pharmaceuticals signs multimillion-dollar licensing deal for its experimental Parkinson's disease treatment bizjournals.com - August 2 at 10:16 PM
	Shares Spike On an Old Drug Being Used As a New Class of Drugs for Parkinson’s Disease baystreet.ca - July 29 at 12:37 PM
	Adhera Signs Definitive License Agreement with Melior Pharmaceuticals II for New Parkinson’s Disease Drug Candidate finance.yahoo.com - July 29 at 12:37 PM

Get Adhera Therapeutics News Delivered to You Automatically

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

ATRX Media Mentions By Week

ATRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATRX
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

ATRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATRX Articles
This Week
▼
0

0
▲
ATRX Articles
Average Week

Get Adhera Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (OTCMKTS:ATRX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Adhera Therapeutics (ATRX) News Today

ATRX Media Mentions By Week

ATRX Media Sentiment

ATRX News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info